DexCom, Inc. (DXCM) — Stock Price, Chart & Analysis
DexCom, Inc. (DXCM) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $33.79B and a trailing P/E ratio of 35.25. Over the past 52 weeks, DXCM has traded between $54.11 and $92.59. DexCom, Inc. does not currently pay a regular dividend. View the live DXCM chart, technical opinion, analyst ratings, fundamentals and latest news below.
DexCom, Inc. (DXCM) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $33.79B |
| P/E ratio (TTM) | 35.25 |
| EPS (TTM) | $2.54 |
| 52-week high | $92.59 |
| 52-week low | $54.11 |
| Beta | 1.42 |
| Avg. volume | 4.70M |
| Sector | Healthcare |
| Industry | Medical Devices |
Frequently asked questions about DexCom, Inc. (DXCM)
How much does one share of DexCom, Inc. cost?
As of the latest update, one share of DexCom, Inc. (DXCM) trades at $100 (+0.00% today).
What is DexCom, Inc.'s market cap?
DexCom, Inc. has a market capitalization of approximately $33.79B.
What is DexCom, Inc.'s P/E ratio?
DexCom, Inc. has a trailing price-to-earnings (P/E) ratio of 35.25.
What is DexCom, Inc.'s earnings per share (EPS)?
DexCom, Inc.'s trailing twelve-month EPS is $2.54.
Does DexCom, Inc. pay a dividend?
DexCom, Inc. does not currently pay a regular dividend.
What is DexCom, Inc.'s 52-week trading range?
Over the past year, DXCM has traded between $54.11 and $92.59.
What is the analyst price target for DexCom, Inc.?
The mean analyst price target for DexCom, Inc. is $94.48. This is informational only and not investment advice.
Latest DexCom, Inc. (DXCM) news
- Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key PlayersNews · Sep 21, 2026
- Dexcom gives CFO Jereme Sylvain expanded roleNews · Sep 16, 2026
- Dexcom Promotes Jereme Sylvain to Chief Operating OfficerNews · Sep 14, 2026
- Dexcom Appoints Glenn Boehnlein to Board of DirectorsNews · Sep 10, 2026
- DexCom Stock: Is DXCM Underperforming the Healthcare Sector?News · Sep 8, 2026
- Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring StocksNews · Sep 3, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live DXCM dashboard…